HCTI — Stock Film
STOCK FILMSCENE 1/11HCTI · $0.75
Stock Expert AI presents
HCTI
Healthcare Triangle, Inc
~5 min film100% real numbersplain English
WHAT DOES THIS COMPANY DO?
Healthcare Triangle, Inc. What it actually does.

Provide cloud services, including multi-cloud migration and management via its CloudEz platform. Now — the numbers.

on the stock market since 2021
40 employees
$862K market value
WHERE DOES THE MONEY COME FROM?
54%Software Services
Software ServicesManaged Services and Support 35%Platform Services 11%
54% of all revenue comes from a single line: Software Services.

The biggest line carries real weight, but it doesn’t decide everything on its own.

Revenue last year:
$13.9M
The loss that same year:
$9.5M
For every $1 it earns, the company spends $1.7.

The company is still in the product-building phase: its spending runs far above its sales. That only changes once the product starts selling at scale.

THE SALES TREND
Sales have been shrinking.

An average decline of 21% a year over the last 4 years — the most striking risk in this picture. Red columns mark years that ended in a loss.

$35.3M
2021
2022
2023
2024
$13.9M
2025
In the vault right now:
$7.6M
DEBT: $10.7M
At this pace, that money lasts less than a year.

Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.

INSIDE THE REPORT CARD

We compared this company with its own sector across five subjects.

A score of 50 means class average.

BUSINESS QUALITY
14
very weak

Clearly below the class average.

FINANCIAL STRENGTH
25
very weak

Clearly below the class average.

VALUATION
17
very weak

Clearly below the class average.

GROWTH
3
very weak

Clearly below the class average.

PRICE MOMENTUM
7
very weak

Clearly below the class average.

WORTH WATCHING

Growth: Sales growth trails the sector average.

Price Momentum: The stock has lagged the market in recent months; investor interest is weak right now.

THE FIVE-YEAR JOURNEY
A long and steep decline.

An investor who bought at the very peak is down 100% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.

1
THE BRIGHT SIDE · 1/3
The product is selling

Sales run at $13.9M a year. A small number, but proof the product has real buyers.

2
THE BRIGHT SIDE · 2/3
Delivers on expectations

It met or beat analyst expectations in 7 of the last 8 quarters — consistency is a promise kept.

3
THE BRIGHT SIDE · 3/3
Executives are buying their own stock

Over the last 12 months, company executives reported 8 buys and 5 sells. Management buying with its own money is usually read as a good sign.

1
THE RISKS · 1/3
Small sales, big loss

A loss of $9.5M against $13.9M in annual sales.

2
THE RISKS · 2/3
Trading under $1

The stock sits at $0.75. Under exchange rules, stocks that stay below $1 for too long risk being removed from the market.

3
THE RISKS · 3/3
The cash has a countdown

At the current pace of spending, the cash lasts less than a year. After that, the company needs to find new money.

FINALE · THE GRADE
grade pending

We don’t have a report card for this stock yet — the data isn’t mature enough to grade. No grade is information too: it means the evidence is thin.

One-line summary: few numbers, an untested story. Keep watching.

What would you like to do next?
Open the stock page →
This was a film — not investment advice.
Data: FMP & company filings
Sep 12, 2026 · stockexpertai.com · Stock Film